XML 92 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2013
FAIR VALUE MEASUREMENTS  
Schedule of cash equivalents, restricted cash and marketable securities by security type

Cash equivalents, restricted cash and marketable securities by security type at December 31, 2013 were as follows:

 
  Amortized
Cost
  Gross
Unrealized
Gains
  Gross
Unrealized
Losses
  Estimated
Fair Value
 
 
  (In thousands)
 

Included in cash and cash equivalents:

                         

Money market funds

  $ 8,079   $   $   $ 8,079  

Corporate notes

    2,206             2,206  
                   

 

  $ 10,285   $   $   $ 10,285  
                   
                   

Restricted cash:

                         

Certificates of deposit

  $ 795   $   $   $ 795  
                   
                   

Marketable securities (due in less than 1 year):

                         

Government-sponsored enterprise securities

  $ 7,369   $ 1   $ (1 ) $ 7,369  

Commercial paper

    5,496     3         5,499  

Corporate notes

    39,383     1     (18 )   39,366  
                   

 

  $ 52,248   $ 5   $ (19 ) $ 52,234  
                   
                   

        Cash equivalents, restricted cash and marketable securities by security type at December 31, 2012 were as follows:

 
  Amortized
Cost
  Gross
Unrealized
Gains
  Gross
Unrealized
Losses
  Estimated
Fair Value
 
 
  (In thousands)
 

Included in cash and cash equivalents:

                         

Money market funds

  $ 15,660   $   $   $ 15,660  

Corporate notes

    3,136         (1 )   3,135  
                   

 

  $ 18,796   $   $ (1 ) $ 18,795  
                   
                   

Restricted cash:

                         

Certificates of deposit

  $ 794   $   $   $ 794  
                   
                   

Marketable securities (due in less than 1 year):

                         

Government-sponsored enterprise securities

  $ 8,618   $ 5   $   $ 8,623  

Commercial paper

    20,623     21         20,644  

Corporate notes

    44,190     22     (7 )   44,205  
                   

 

  $ 73,431   $ 48   $ (7 ) $ 73,472  
                   
                   
Schedule of cash equivalents and marketable securities with unrealized losses

Cash equivalents and marketable securities with unrealized losses at December 31, 2013 and 2012 were as follows:

 
  Less Than 12 Months   12 Months or Greater   Total  
 
  Estimated
Fair Value
  Gross
Unrealized
Losses
  Estimated
Fair Value
  Gross
Unrealized
Losses
  Estimated
Fair Value
  Gross
Unrealized
Losses
 
 
  (In thousands)
 

As of December 31, 2013:

                                     

Government-sponsored enterprise securities (due in less than 1 year)

  $ 3,947   $ (1 ) $   $   $ 3,947   $ (1 )

Corporate notes (due in less than 1 year)

    37,060     (18 )               37,060     (18 )
                           

 

  $ 41,007   $ (19 ) $   $   $ 41,007   $ (19 )
                           
                           

As of December 31, 2012:

                                     

Corporate notes (due in less than 1 year)

  $ 27,045   $ (8 ) $   $   $ 27,045   $ (8 )
                           
                           
Schedule of non-employee options to purchase common stock considered as derivatives and classified as current liabilities

 

 

 
   
  Number of Shares at
December 31,
   
   
  Fair Value at
December 31,
 
 
  Exercise
Price
  Exercisable
Date
  Expiration
Date
 
Issuance Date
  2013   2012   2013   2012  
 
   
   
   
   
   
  (In thousands)
 

March 2005

  $ 6.39     284,600     284,600   January 2007   March 2015   $ 367   $ 51  
                                     
                                     
Schedule of assumptions used to estimate the fair value of derivatives

The fair value of derivatives has been calculated at each reporting date using the Black Scholes option-pricing model with the following assumptions:

 
  December 31,
 
  2013   2012

Dividend yield

  None   None

Expected volatility

  0.844   0.828

Risk-free interest rate

  0.13%   0.25%

Expected term

  1 yr   2 yrs
Schedule of financial instruments measured at fair value on recurring basis

The following table presents information about our financial instruments that are measured at fair value on a recurring basis as of December 31, 2013 and indicates the fair value category assigned.

 
  Fair Value Measurements at Reporting Date Using  
 
  Quoted Prices in
Active Markets for
Identical Assets/
Liabilities
  Significant
Other
Observable
Inputs
  Significant
Unobservable
Inputs
   
 
(In thousands)
  Level 1   Level 2   Level 3   Total  

Assets

                         

Money market funds(1)

  $ 8,079   $   $   $ 8,079  

Government-sponsored enterprise securities(2)

        7,369         7,369  

Commercial paper(2)

        5,499         5,499  

Corporate notes(1)(2)

        41,572         41,572  
                   

Total

  $ 8,079   $ 54,440   $   $ 62,519  
                   
                   

Liabilities

                         

Derivatives(3)

  $   $   $ 367   $ 367  
                   
                   

        The following table presents information about our financial instruments that are measured at fair value on a recurring basis as of December 31, 2012 and indicates the fair value category assigned.

 
  Fair Value Measurements at Reporting Date Using  
 
  Quoted Prices in
Active Markets for
Identical Assets/
Liabilities
  Significant
Other
Observable
Inputs
  Significant
Unobservable
Inputs
   
 
(In thousands)
  Level 1   Level 2   Level 3   Total  

Assets

                         

Money market funds(1)

  $ 15,660   $   $   $ 15,660  

Government-sponsored enterprise securities(2)

        8,623         8,623  

Commercial paper(2)

        20,644         20,644  

Corporate notes(1)(2)

        47,340         47,340  
                   

Total

  $ 15,660   $ 76,607   $   $ 92,267  
                   
                   

Liabilities

                         

Derivatives(3)

  $   $   $ 51   $ 51  
                   
                   

(1)
Included in cash and cash equivalents on our consolidated balance sheets.

(2)
Included in current marketable securities on our consolidated balance sheets.

(3)
Included in fair value of derivatives on our consolidated balance sheets.
Schedule of rollforward of the balance sheet amounts for financial instruments in Level 3 category

 

 

 
  Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Year Ended December 31, 2013
 
(In thousands)
  Fair Value at
December 31,
2012
  Total
Unrealized
Loss
Included in
Earnings(1)
  Purchases,
Sales,
Issuances,
Settlements
  Transfers
In and/or
Out of
Level 3
  Fair Value at
December 31,
2013
  Change in
Unrealized Loss
Related to
Financial
Instruments
Held at
December 31,
2013(1)
 

Derivative liabilities

  $ 51   $ 316   $   $   $ 367   $ 316  

(1)
Reported as unrealized loss on derivatives in our consolidated statements of operations.